ProSomnus, Inc. (OSA) Stock Forecast & Analysis
Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for ProSomnus, Inc. (OSA:NASDAQ), powered by AI.
- Current Price
- $30.00
- P/E Ratio
- 0.1
- Market Cap
- 12.1B
- Sector
- Healthcare
What is the ProSomnus, Inc. stock price forecast?
ProSomnus, Inc. is currently trading at $30.00. View real-time AI analysis on Alpha Lenz.
What is ProSomnus, Inc. insider trading activity?
View the latest insider trading data for ProSomnus, Inc. on Alpha Lenz.
What is ProSomnus, Inc.'s P/E ratio?
ProSomnus, Inc.'s P/E ratio is 0.1.
ProSomnus, Inc.
NASDAQ · OSA“ProSomnus, Inc. trades at a P/E of 0.1 (undervalued) with strong ROE of 15.8%.”
Ask for details →Company Overview
ProSomnus, Inc. operates as a medical technology company that develops, manufactures, and markets precision intraoral medical devices for treating and managing patients with obstructive sleep apnea. The company sells its products to sleep dentists, sleep physicians, primary care providers, otolaryngologists, and other integrated healthcare service providers through a direct sales force. ProSomnus, Inc. is headquartered in Pleasanton, California.
Company Statistics
FY 2025Profile
Margins
Valuation
Growth (CAGR)
Returns
Financial Health
“ProSomnus, Inc. trades at a P/E of 0.1 (undervalued) with strong ROE of 15.8%.”
Ask for details →Frequently Asked Questions
ProSomnus, Inc. (ticker: OSA) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 136 employees. Market cap is $12.1B.
The current price is $30 with a P/E ratio of 0.09x and P/B of 0.01x.
ROE is 15.83% and operating margin is 7.77%. Annual revenue is $2.1T.